As of 10:28:11 AM GMT+1. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
595,344.00
410,609.00
479,792.00
161,152.00
Total Liabilities Net Minority Interest
224,412.00
139,826.00
133,538.00
65,692.00
Total Equity Gross Minority Interest
370,932.00
270,783.00
346,254.00
95,460.00
Total Capitalization
401,630.00
301,098.00
376,127.00
109,965.00
Common Stock Equity
370,932.00
270,783.00
346,254.00
95,460.00
Capital Lease Obligations
14,258.00
14,010.00
14,464.00
1,270.00
Net Tangible Assets
370,932.00
270,783.00
346,254.00
95,460.00
Working Capital
492,331.00
316,041.00
422,317.00
132,594.00
Invested Capital
401,630.00
301,098.00
376,127.00
109,965.00
Tangible Book Value
370,932.00
270,783.00
346,254.00
95,460.00
Total Debt
44,956.00
44,325.00
44,337.00
15,775.00
Share Issued
42,431.77
29,873.89
29,579.36
21,094.56
Ordinary Shares Number
42,431.77
29,873.89
29,579.36
21,094.56
12/31/2020 - 5/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
698.BE Achilles Therapeutics PLC
0.9500
+2.15%
688428.SS InnoCare Pharma Limited
13.39
-1.76%
MRNA.VI Moderna, Inc.
39.87
-1.47%
SLNCF Silence Therapeutics plc
2.0000
0.00%
EVLO Evelo Biosciences, Inc.
0.0004
-20.00%
2171.HK CARsgen Therapeutics Holdings Limited
9.650
-0.31%
5CV.DE CureVac N.V.
2.9800
-0.93%
BION.SW BB Biotech AG Ord
36.00
-0.41%
OXB.L Oxford Biomedica plc
423.50
0.00%
KALV KalVista Pharmaceuticals, Inc.
9.00
+3.57%